AJP - Heart and Circulatory Physiology, Vol 260, Issue 3 877-H883, Copyright © 1991 by American Physiological Society

ARTICLES

Role of phospholipases A2 and C in myocardial ischemic reperfusion injury

M. R. Prasad, L. M. Popescu, I. I. Moraru, X. K. Liu, S. Maity, R. M. Engelman and D. K. Das
Department of Surgery, University of Connecticut School of Medicine, Farmington 06032.

We investigated the role of phospholipase A2 (PLA2) and phospholipase C (PLC) in myocardial phosholipid degradation and cellular injury during reperfusion of ischemic myocardium. For this purpose, isolated rat hearts were perfused with isotopic arachidonic acid to label its membrane phospholipids. Hearts preperfused with antiphospholipase A2 (anti-PLA2) retained a significantly higher amount of radiolabel in phosphatidylcholine and phosphatidylinositol and a corresponding lower amount of radiolabel in lysophosphatidylcholine and nonesterified fatty acids (P less than 0.05) after 30 min of reperfusion following 30 min of normothermic global ischemia compared with hearts preperfused with nonimmune immunoglobulin G. In similar experiments, antiphospholipase C (anti-PLC)-treated hearts were associated with significantly (P less than 0.05) higher radiolabel in all phospholipids and lower radiolabel in diacyglycerol compared with nonimmune immunoglobulin G-treated hearts. Measurement of phospholipase activity in subcellular organelles of these hearts showed decreased PLA2 activity in cytosol, mitochondria, and microsomes of anti-PLA2-treated hearts and decreased PLC activity of microsomes in anti-PLC-treated hearts. Furthermore, both the antiphospholipases attenuated the release of creatine kinase and lactate dehydrogenase into perfusate and increased contractility as well as coronary flow in the reperfused hearts. Results of this study suggest that both PLA2 and PLC are involved in the degradation of phospholipids and cellular injury that occur during reperfusion of ischemic myocardium.

This article has been cited by other articles:

				H. Kitagawa, T. Yamazaki, T. Akiyama, M. Sugimachi, K. Sunagawa, and H. Mori Microdialysis separately monitors myocardial interstitial myoglobin during ischemia and reperfusion Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H924 - H930. [Abstract] [Full Text] [PDF]

				G. Van Den Thillart, G. Vianen, M. C. Ponce, H. Lelieveld, M. Nieveen, M. Van Raaij, A. Steffens, and J. Zaagsma Differential role of adrenoceptors in control of plasma glucose and fatty acids in carp, Cyprinus carpio (L.) Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2001; 281(2): R615 - R624. [Abstract] [Full Text] [PDF]

				R. N. M. Cornelussen, G. J. Van Der Vusse, T. H. M. Roemen, and L. H. E. H. Snoeckx Heat pretreatment differentially affects cardiac fatty acid accumulation during ischemia and postischemic reperfusion Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1736 - H1743. [Abstract] [Full Text] [PDF]

				J. McHowat, P. S. Tappia, S.-Y. Liu, R. McCrory, and V. Panagia Redistribution and abnormal activity of phospholipase A2 isoenzymes in postinfarct congestive heart failure Am J Physiol Cell Physiol, March 1, 2001; 280(3): C573 - C580. [Abstract] [Full Text] [PDF]

				S. D. Williams, F.-F. Hsu, and D. A. Ford Electrospray ionization mass spectrometry analyses of nuclear membrane phospholipid loss after reperfusion of ischemic myocardium J. Lipid Res., October 1, 2000; 41(10): 1585 - 1595. [Abstract] [Full Text]

				M. C. LaPointe and E. Isenovic Interleukin-1ß Regulation of Inducible Nitric Oxide Synthase and Cyclooxygenase-2 Involves the p42/44 and p38 MAPK Signaling Pathways in Cardiac Myocytes Hypertension, January 1, 1999; 33(1): 276 - 282. [Abstract] [Full Text] [PDF]

				A. Tosaki, N. Maulik, G. Cordis, O. C. Trifan, L. M. Popescu, and D. K. Das Ischemic preconditioning triggers phospholipase D signaling in rat heart Am J Physiol Heart Circ Physiol, October 1, 1997; 273(4): H1860 - H1866. [Abstract] [Full Text] [PDF]